Supervisor Database Search
Guidance for ICAT Supervisors
The ICAT Supervisor list is reviewed annually by the partner universities and updated online in March/April each year.
You can read about the ICAT supervisor selection process and eligibility criteria below:
Terms of reference/guide to supervising ICAT Fellows.
You can read the terms of reference for supervisors actively supervising ICAT Fellows below:
Supervisor Database
Search for supervisors below. You can filter your search using the options and select multiple fields by holding CTRL (Cmd on Mac) + clicking multiple options in a list.
Full NameDr Patrick Walsh
- Other
Crohn’s, colitis, psoriasis, Coeliac, Cytokines, IL-1 family, barrier tissue sites
- Medicine
- Paediatrics
- Adolescent medicine
- Dermatology
- Gastroenterology
- Infectious diseases
- Immunology
The research conducted by my group investigates the mechanisms which control inflammation, with the aim of identifying new avenues for treating autoimmune and inflammatory disease conditions in humans. We take a translational research approach, using both preclinical models and patient samples, to investigate novel mechanisms implicated in the pathogenesis of diseases such as psoriasis and inflammatory bowel disease. Our primary goal is to identify novel targets for therapeutic intervention for patients suffering from these diseases. My laboratories are located at Trinity Translational Medicine Institute and the National Children’s Research Centre at Children’s Health Ireland, Crumlin allowing close collaboration with clinician scientists to facilitate these studies. We also collaborate closely with colleagues in the pharmaceutical industry to advance ongoing drug development programmes.
Current areas of focus include uncovering the role of novel Interleukin-1 family members in inflammation and autoimmune disease. Recent findings in this area include the following (Life Sci. Alliance 2020 3(4), Nature Commun. 2019 10(1):4003, Mucosal Immunol. 2016, 9(5):1193. 2022, 15(3):491-503. J. Immunol. 2013 ,191(6):3337. 2022, 207(2):651-660) .
Novel drug target discovery for chronic gastrointestinal diseases including IBD and Coeliac disease using existing in house transcriptomic single cell RNAseq and Digital spatial transcriptomic data sets.
https://www.biorxiv.org/content/10.1101/2025.03.05.641653v1.abstract